Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbCellera Biologics

3.41
-0.0600-1.73%
Post-market: 3.440.0300+0.88%19:59 EDT
Volume:8.76M
Turnover:29.47M
Market Cap:1.02B
PE:-6.00
High:3.55
Open:3.50
Low:3.24
Close:3.47
Loading ...
Feb 20, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 29, 2023

Major Issues Report

Form 8-K - Current report
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 13, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 21, 2023

Major Issues Report

Form 8-K - Current report
May 25, 2023

Major Issues Report

Form 8-K - Current report
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 24, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 13, 2023

Major Issues Report

8-K - Current report
Feb 21, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 21, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 21, 2023

Major Issues Report

8-K - Current report
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals